Bifogade filer
PDF
Kurs
-0,83%
Likviditet
0,20 MSEK
Kalender
| Tid* | ||
| 2023-02-24 | - | Bokslutskommuniké 2022 |
| 2022-11-29 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-25 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-06 | - | X-dag ordinarie utdelning BRIG 0.00 SEK |
| 2022-05-04 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-28 | - | Bokslutskommuniké 2021 |
| 2021-12-07 | - | Extra Bolagsstämma 2021 |
| 2021-11-15 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-12 | - | Kvartalsrapport 2021-Q2 |
| 2021-06-17 | - | Årsstämma |
| 2021-05-18 | - | X-dag ordinarie utdelning BRIG 0.00 SEK |
| 2021-05-12 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-26 | - | Bokslutskommuniké 2020 |
| 2020-11-20 | - | Extra Bolagsstämma 2020 |
| 2020-11-06 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-31 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-16 | - | X-dag ordinarie utdelning BRIG 0.00 SEK |
| 2020-06-15 | - | Årsstämma |
| 2020-04-30 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-27 | - | Bokslutskommuniké 2019 |
| 2019-11-11 | - | Extra Bolagsstämma 2019 |
| 2019-10-25 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-28 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-22 | - | Kvartalsrapport 2019-Q1 |
| 2019-05-10 | - | X-dag ordinarie utdelning BRIG 0.00 SEK |
| 2019-05-09 | - | Årsstämma |
| 2019-02-27 | - | Bokslutskommuniké 2018 |
| 2018-11-15 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-24 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-17 | - | X-dag ordinarie utdelning BRIG 0.00 SEK |
| 2018-05-16 | - | Årsstämma |
| 2018-04-20 | - | Kvartalsrapport 2018-Q1 |
| 2018-03-23 | - | Bokslutskommuniké 2017 |
| 2017-11-24 | - | Kvartalsrapport 2017-Q3 |
| 2017-09-29 | - | Extra Bolagsstämma 2017 |
| 2017-08-25 | - | Kvartalsrapport 2017-Q2 |
| 2017-06-12 | - | X-dag ordinarie utdelning BRIG 0.00 SEK |
| 2017-06-09 | - | Årsstämma |
| 2017-05-19 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-24 | - | Bokslutskommuniké 2016 |
| 2016-11-25 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-26 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-20 | - | Kvartalsrapport 2016-Q1 |
| 2016-05-18 | - | X-dag ordinarie utdelning BRIG 0.00 SEK |
| 2016-05-17 | - | Årsstämma |
| 2016-04-22 | - | X-dag ordinarie utdelning BRIG 0.00 SEK |
| 2016-03-31 | - | Bokslutskommuniké 2015 |
| 2015-12-11 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-28 | - | Kvartalsrapport 2015-Q2 |
| 2015-06-15 | - | X-dag ordinarie utdelning BRIG 0.00 SEK |
| 2015-06-12 | - | Årsstämma |
| 2015-06-05 | - | Kvartalsrapport 2015-Q1 |
| 2015-03-31 | - | Bokslutskommuniké 2014 |
| 2014-11-14 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-15 | - | Kvartalsrapport 2014-Q2 |
| 2014-06-19 | - | X-dag ordinarie utdelning BRIG 0.00 SEK |
| 2014-06-18 | - | Årsstämma |
| 2014-05-09 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-06 | - | Bokslutskommuniké 2013 |
| 2013-11-14 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-15 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-23 | - | X-dag ordinarie utdelning BRIG 0.00 SEK |
| 2013-05-22 | - | Årsstämma |
| 2013-05-08 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-20 | - | Bokslutskommuniké 2012 |
| 2012-12-05 | - | 15-7 2012 |
| 2012-11-14 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-31 | - | Kvartalsrapport 2012-Q2 |
| 2012-06-21 | - | X-dag ordinarie utdelning BRIG 0.00 SEK |
| 2012-06-20 | - | Årsstämma |
| 2012-05-08 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-29 | - | Bokslutskommuniké 2011 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, HONGKONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.
The Board of Directors of Brighter AB (publ) ("Brighter" or the "Company") expands on the previously announced loan financing with Formue Nord Markedsneutral of SEK 10.0 million. The loan financing is expanded with SEK 2.5 million and will cover running operational costs until the completion of the Company's ongoing rights issue. The loan financing is procured with a monthly interest of 2.0 percent, in line with the earlier procured loan from Formue Nord Markedsneutral. The loan financing is intended to be repaid with capital raised from the ongoing rights issue.
For more information, please contact:
Investor Relations
IR@brighter.se
Certified Adviser
Brighter's Certified Adviser is Mangold Fondkommission AB,
+46 8 52 77 5020, ca@mangold.se,www.mangold.se
About Brighter
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers - aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO13485 certified. In 2019 the Company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG. For more information, please visit our website at www.brighter.se.
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on 2022-09-13 at 14:00 CEST.